249 related articles for article (PubMed ID: 20099992)
1. A clinical review of statins and cancer: helpful or harmful?
Gonyeau MJ; Yuen DW
Pharmacotherapy; 2010 Feb; 30(2):177-94. PubMed ID: 20099992
[TBL] [Abstract][Full Text] [Related]
2. Statin use and cancer risk: an epidemiologic review.
Friis S; Olsen JH
Cancer Invest; 2006; 24(4):413-24. PubMed ID: 16777695
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
4. Statin use and breast cancer: prospective results from the Women's Health Initiative.
Cauley JA; McTiernan A; Rodabough RJ; LaCroix A; Bauer DC; Margolis KL; Paskett ED; Vitolins MZ; Furberg CD; Chlebowski RT;
J Natl Cancer Inst; 2006 May; 98(10):700-7. PubMed ID: 16705124
[TBL] [Abstract][Full Text] [Related]
5. Therapy insight: Potential of statins for cancer chemoprevention and therapy.
Katz MS
Nat Clin Pract Oncol; 2005 Feb; 2(2):82-9. PubMed ID: 16264880
[TBL] [Abstract][Full Text] [Related]
6. The role of statins in cancer therapy.
Hindler K; Cleeland CS; Rivera E; Collard CD
Oncologist; 2006 Mar; 11(3):306-15. PubMed ID: 16549815
[TBL] [Abstract][Full Text] [Related]
7. The statin studies: from targeting hypercholesterolaemia to targeting the high-risk patient.
Ong HT
QJM; 2005 Aug; 98(8):599-614. PubMed ID: 16006501
[TBL] [Abstract][Full Text] [Related]
8. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
Mora S; Ridker PM
Am J Cardiol; 2006 Jan; 97(2A):33A-41A. PubMed ID: 16442935
[TBL] [Abstract][Full Text] [Related]
9. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
10. The role of statins in heart failure.
Gullestad L; Oie E; Ueland T; Yndestad A; Aukrust P
Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():35-40. PubMed ID: 18001320
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
[TBL] [Abstract][Full Text] [Related]
12. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
[TBL] [Abstract][Full Text] [Related]
13. Diverse effects of statins on angiogenesis: new therapeutic avenues.
Elewa HF; El-Remessy AB; Somanath PR; Fagan SC
Pharmacotherapy; 2010 Feb; 30(2):169-76. PubMed ID: 20099991
[TBL] [Abstract][Full Text] [Related]
14. Effects of statins and farnesyltransferase inhibitors on the development and progression of cancer.
Graaf MR; Richel DJ; van Noorden CJ; Guchelaar HJ
Cancer Treat Rev; 2004 Nov; 30(7):609-41. PubMed ID: 15531395
[TBL] [Abstract][Full Text] [Related]
15. Statins and clinical outcomes in heart failure.
Martin JH; Krum H
Clin Sci (Lond); 2007 Aug; 113(3):119-27. PubMed ID: 17600528
[TBL] [Abstract][Full Text] [Related]
16. Statins and cancer risk: what do we know and where do we go from here?
Moorman PG; Hamilton RJ
Epidemiology; 2007 Mar; 18(2):194-6. PubMed ID: 17301705
[TBL] [Abstract][Full Text] [Related]
17. Use of statins and fracture: results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials.
Bauer DC; Mundy GR; Jamal SA; Black DM; Cauley JA; Ensrud KE; van der Klift M; Pols HA
Arch Intern Med; 2004 Jan; 164(2):146-52. PubMed ID: 14744837
[TBL] [Abstract][Full Text] [Related]
18. Potential antitumor effects of statins (Review).
Jakobisiak M; Golab J
Int J Oncol; 2003 Oct; 23(4):1055-69. PubMed ID: 12963986
[TBL] [Abstract][Full Text] [Related]
19. Statins and cancer risk.
Karp I; Behlouli H; Lelorier J; Pilote L
Am J Med; 2008 Apr; 121(4):302-9. PubMed ID: 18374689
[TBL] [Abstract][Full Text] [Related]
20. Perspectives of the non-statin hypolipidemic agents.
Rozman D; Monostory K
Pharmacol Ther; 2010 Jul; 127(1):19-40. PubMed ID: 20420853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]